// company-profile

MoonLake Immunotherapeutics

MLTX
ExchangeNasdaqSectorPharmaceutical PreparationsInc.E9Filings65Insiders24
// api This MoonLake Immunotherapeutics insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares. Buying was led by Moukheibir Catherine.

// 90-day insight

Over the last 90 days, MoonLake Immunotherapeutics insiders bought $0 (5 transactions) and sold $65.7M (5 transactions).

  • Most active insider: Bodenstedt Matthias with 6 transactions totaling $2.3M.
  • Largest single sale: $32.4M by BVF PARTNERS L P/IL on Mar 31, 2026.
  • 64% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity is mixed — buys and sales are roughly balanced.

Institutional Ownership

Top 13F-HR holders of MoonLake Immunotherapeutics as of 2026-03-31

↑ increasing
Total reported AUM
$1.15B
QoQ change
+52.2%
Reporting period
2026-03-31
#1
BVF INC/IL
CIK 1056807
$298.3M
16.0M shares
#2
Deep Track Capital, LP
CIK 1856083
$119.5M
6.4M shares
#3
Cormorant Asset Management, LP
CIK 1583977
$83.5M
4.5M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 18, 2026Bodenstedt MatthiasMLTX
Sale10b5
2,794$19.60$55K
Jun 17, 2026Moukheibir CatherineMLTX
Award
22,195$0.00$0K
Jun 17, 2026Phillips Andrew JohnMLTX
Award
22,195$0.00$0K
Jun 17, 2026Xavier RamnikMLTX
Award
22,195$0.00$0K
Jun 17, 2026BVF PARTNERS L P/ILMLTX
Award
22,195$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.